USPSTF Backs Cervical Cancer Screening With Cytology or hrHPV
Recommendations for screening with cytology alone every three years or hrHPV testing every five years
AACR Releases 2017 Cancer Progress Report
Twenty-five percent decrease in age-adjusted U.S. cancer death rate from 1991 to 2014
Some Aspects of Empathy Improve During Medical Training
Decrease in empathy as assessed by JSPE, but overall cognitive empathy improved on the QCAE
Antibiotic Rx Adherence Varies Widely in Sickle Cell Care
Guideline-adherent therapy tied to fewer 30-day readmissions
Most Opioid Use Concentrated in Top 10 Percent of Users
Top 10 percent of users accounted for 76 percent of the total annual morphine equivalents
Adjuvant Nivolumab Tops Ipilimumab in Melanoma
Longer recurrence-free survival for stage IIIB, IIIC, IV melanoma
Are Physicians Obligated to Help on Planes?
One administrative physician explains his sense of obligation to help
Dabrafenib, Trametinib Beneficial in Resected Melanoma
Rate of relapse-free survival up for resected stage III melanoma with BRAF V600E, V600K mutations
Longer Progression-Free Survival for Durvalumab in NSCLC
Longer median progression-free survival from randomization, higher response rate with durvalumab
Median Cost of Cancer Drug Development $648.0 Million
Total revenue from sales of 10 drugs was $67.0 billion, with total R&D spending of $7.2 billion
